Vitamin D Pilot Study in Patients With Multiple Sclerosis

Completed · Phase 1

Conditions studied: Relapsing Remitting Multiple Sclerosis

In brief

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Key facts

Study ID

NCT01257958

Run by

University of Wisconsin, Madison

Starts

1998-02-01

Expected to finish

2000-06-01

Last updated by the study team

2015-10-05

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• relapsing remitting MS

You may not qualify if…

• MRI contraindicated

Where it is running

• UW-Madison — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.